---  
layout: startup_page  
title: "AusperBio Therapeutics"  
id: "ausperbio.com"  
permalink: "/ausperbiotherapeuticsausperbio.com05282025/"  
website: "https://www.ausperbio.com/"  
funding_round: "Series B+"  
funding_amount: "$50M"  
investors: "Qiming Venture Partners, CDH Investments, Genesis Capital, YuanBio Venture Capital, HanKang Capital, Sherpa Capital"  
about: "AusperBio is a clinical-stage biotechnology company focused on advancing targeted oligonucleotide therapies to achieve a functional cure for chronic hepatitis B (CHB). They are developing AHB-137, a novel unconjugated antisense oligonucleotide, and are committed to delivering patient-centered innovations to alleviate the global health burden of CHB."  
markets: "Biotech, Healthcare, Pharmaceuticals"  
hq: "San Francisco, California, United States"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/ausperbio"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/ausperbio"  
pitchbook: "https://pitchbook.com/profiles/company/510510-34"  

date_display: "28-May-2025"  
date: "2025-05-28"

# SEO Optimization  
meta_title: "AusperBio Therapeutics - Series B+ Funding ($50M)"  
meta_description: "AusperBio Therapeutics, AusperBio is a clinical-stage biotechnology company focused on advancing targeted oligonucleotide therapies to achieve a functional cure for chronic h..."  
meta_keywords: "AusperBio Therapeutics, Biotech, Healthcare, Pharmaceuticals, Series B+ funding"  
canonical_url: "https://startup.projectstartups.com/ausperbiotherapeuticsausperbio.com05282025/"  
---